M. Nassir

发表

PHENYTOIN INDUCED ERYTHEMATOSUS RASH IN A DIABETIC SEIZURE PATIENT

M. Adil, S. Amir, K. Amer, 2013 .

Is endometrial cancer really a neurophobic tumor? A case report and review of the literature.

C. Mawrin, J. Sehouli, C. Fotopoulou, 2014, Anticancer research.

Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial.

J. Blohmer, S. Kümmel, W. Lichtenegger, 2014, Anticancer research.

The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients—results from the OVCAD study

R. Zeillinger, I. Vergote, N. Concin, 2016, Tumor Biology.

Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort

D. Horn, B. Rau, D. Hartmann, 2022, Cancers.

Prediction of clinical response to drugs in ovarian cancer using the chemotherapy resistance test (CTR-test)

A. Kopp-Schneider, J. Sehouli, I. Braicu, 2017, Journal of Ovarian Research.

High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders

M. Höltje, M. Schemann, H. Prüss, 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Inflammatory bowel disease (IBD)-like disease in a case of a 33-year old man with glycogenosis 1b

M. S. Volz, M. von Winterfeld, B. Siegmund, 2015, BMC Gastroenterology.

HE4 tissue expression in borderline ovarian tumors: a pilot study by the tumorbank ovarian cancer network.

C. Denkert, S. Darb-Esfahani, J. Sehouli, 2013, Anticancer research.

HE4 Expression in Plasma Correlates with Surgical Outcome and Overall Survival in Patients with First Ovarian Cancer Relapse

J. Sehouli, C. Hall, C. Fotopoulou, 2014, Annals of Surgical Oncology.

Enigmatic meningitis in a patient with T cell lymphoma

I. Anagnostopoulos, M. Nassir, S. Schwartz, 2015, Annals of Hematology.

Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab

H. Fiegl, J. Sehouli, A. Zeimet, 2015, Oncotarget.

Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network

S. Darb-Esfahani, J. Sehouli, E. Braicu, 2016, Annals of Surgical Oncology.

Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) – a study of the TOC Consortium

D. Timmerman, I. Vergote, J. Sehouli, 2014, Journal of Ovarian Research.

[Benign recurring aseptic meningitis. What requires our attention?].

M. Nassir, T. Schneider, M. Godbersen, 2016, Der Internist.

ERCC1 expression as a predictor of resistance to platinum-based chemotherapy in primary ovarian cancer.

J. Sehouli, I. Braicu, R. Arsenić, 2014, Anticancer research.